SMA Europe

Wegbeschreibung Website Kontaktieren Sie die Organisation

SMA Europe SMA Europe is a non-profit umbrella organisation of SMA patient organisations from across Europe.

12/11/2026

📣 Reminder: our next SMAcademy webinar is coming up soon!

“Tracing patient experiences with SMA medicines, access, and treatment journeys in Europe: Open discussion on SMA Europe’s Pan-European Patient-Experience Survey”

🗓️ 17 November 2026
⏰ 14:00–15:30 CET

The SMA medicine and treatment landscape is changing rapidly. But how are people living with SMA navigating this increasingly complex environment?

To better understand these experiences, SMA Europe conducted the European Patient Experience Survey (EUPESMA), exploring access to SMA medicines and individual treatment journeys across Europe. The findings reveal that treatment journeys are not always straightforward. They can involve disruptions, delays and changes in direction, highlighting the importance of understanding individual experiences to improve care, support and advocacy.

💬 Join us for an interactive discussion!

We will share key findings from 826 people living with SMA and caregivers across more than 40 countries, while inviting patient advocates to reflect on the results and explore how we can turn these insights into meaningful action.

📌 Please note that the Q&A session will be open to patient advocates only.

🔗 There is still time to register here: https://bit.ly/481o6D1

Together, 🌍



[Description of slides. Slide one: Blue slide reminding readers about the upcoming SMAcademy webinar, “Tracing patient experiences with SMA medicines, access, and treatment journeys in Europe: Open discussion on SMA Europe’s Pan-European Patient-Experience Survey,” taking place on 17 November 2026 from 14:30 to 16:00 CET. It notes that the SMAcademy Webinar Series is designed for patient advocates and that the Q&A session will be open to patient advocates only. Slide two: Blue closing slide with the SMA Europe logo, , and www.sma-europe.eu.]

11/11/2026

Advances in SMA treatment are transforming care. But how can these advances translate into meaningful improvements in everyday life?

Preventing and managing fractures, contractures and musculoskeletal deformities remains important for supporting long-term function and quality of life.

At our 2nd Clinical and Care Symposium on SMA, experts in orthopaedics, physiotherapy and rehabilitation, neurology, paediatrics, pulmonology and endocrinology will explore how multidisciplinary care can respond to evolving needs.

📢 Researching long-term outcomes or quality of life in SMA? We invite you to share your findings by submitting an abstract!

⏳ Deadline: 30 November 2026

📅 4–5 March 2027
📍 Prague, Czechia
💻 Attend in person or online: https://www.sma-europe.eu/clinical-care-symposium-prague-2027

🔗 Learn more and register through the link: https://www.sma-europe.eu/clinical-care-symposium-prague-2027



[Description of images. Slide one: Portrait of Juan F. Vázquez-Costa, Neurologist at the University of Valencia. The slide features the SMA Europe logo and the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation.” Slide two: Green slide featuring a quote from Juan F. Vázquez-Costa: “The advent of disease-modifying therapies has transformed SMA into a condition where preserving long-term function is achievable. Thus, improving motor outcomes, preventing fractures, contractures, and musculoskeletal deformities is more important than ever to ensure that neurologic gains translate into meaningful independence and quality of life.” Slide three: Photograph of a young boy wearing a green T-shirt and leg orthoses, sitting on a white horse with his arms extended for balance while two adults walk alongside and provide support outdoors. The slide includes the SMA Europe logo and symposium theme. Slide four and five: Green slide introducing the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation,” with the dates 4–5 March 2027 and location Prague, Czech Republic. Slide six: Orange closing slide featuring the SMA Europe logo, , and [www.sma-europe.eu](http://www.sma-europe.eu).]

Community Update! 📣SMA Europe actions around recent Zolgensma safety concernsTogether with the families whose children h...
10/11/2026

Community Update! 📣

SMA Europe actions around recent Zolgensma safety concerns

Together with the families whose children have received Zolgensma (onasemnogene abeparvovec) gene therapy, SMA Europe is closely following the emerging safety information and is very aware of the worry and uncertainty this may cause for families in our community.

Please read here for the full community update and the actions we take to keep our community informed and what actions have been already taken to deliver the most updated and transparent information.

https://www.sma-europe.eu/news/sma-europe-actions-around-recent-zolgensma-safety-concerns?ref=%2Fnews

All together. One goal.

09/11/2026

Managing musculoskeletal complications in SMA requires collaboration across different medical specialities.

At our 2nd Clinical and Care Symposium on SMA, experts in orthopaedics, physiotherapy and rehabilitation, neurology, paediatrics, pulmonology and endocrinology will contribute to discussions on clinical decision-making and best practice models.

Together, we can explore ways to support more consistent, multidisciplinary and person-centred care.

Have research findings or clinical insights to share? Contribute to the scientific exchange by submitting your abstract!

Deadline: 30 November 2026

📅 4–5 March 2027
📍 Prague, Czechia
💻 In-person and online participation available!

🔗 Learn more via the link in our bio.



[Description of images. Slide one: Portrait of Jana Haberlová, Paediatric Neurologist at University Hospital Motol, Prague. The slide features the SMA Europe logo and the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation.” Slide two: Green slide featuring a quote from Jana Haberlová: “The symposium will provide a unique platform for multidisciplinary discussions on the evolving standards of SMA clinical care. Key sessions will address current challenges in prevention, monitoring, rehabilitation, and both surgical and non-surgical management.” Slide three: Close-up photograph of a child seated in a supportive wheelchair, wearing a colourful pink and purple spinal orthosis with black fastening straps. The slide includes the SMA Europe logo and symposium theme. Slide four: Green slide introducing the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation,” with the dates 4–5 March 2027 and location Prague, Czech Republic. Slide five: Green slide announcing the 2nd International Clinical Care Symposium on Spinal Muscular Atrophy, taking place on 4–5 March 2027 in Prague, Czech Republic. Slide six: Orange closing slide featuring the SMA Europe logo, WeAreOne, SpinalMuscularAtrophy and [www.sma-europe.eu](http://www.sma-europe.eu).]

09/11/2026

Managing musculoskeletal complications in SMA requires collaboration across different medical specialities.

At our 2nd Clinical and Care Symposium on SMA, experts in orthopaedics, physiotherapy and rehabilitation, neurology, paediatrics, pulmonology and endocrinology will contribute to discussions on clinical decision-making and best practice models.

Together, we can explore ways to support more consistent, multidisciplinary and person-centred care.

📢 Have research findings or clinical insights to share? Contribute to the scientific exchange by submitting your abstract!

⏳ Deadline: 30 November 2026

📅 4–5 March 2027
📍 Prague, Czechia
💻 In-person and online participation available here: https://www.sma-europe.eu/clinical-care-symposium-prague-2027

🔗 Learn more and register through the link: https://www.sma-europe.eu/clinical-care-symposium-prague-2027



[Description of images. Slide one: Portrait of Jana Haberlová, Paediatric Neurologist at University Hospital Motol, Prague. The slide features the SMA Europe logo and the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation.” Slide two: Green slide featuring a quote from Jana Haberlová: “The symposium will provide a unique platform for multidisciplinary discussions on the evolving standards of SMA clinical care. Key sessions will address current challenges in prevention, monitoring, rehabilitation, and both surgical and non-surgical management.” Slide three: Close-up photograph of a child seated in a supportive wheelchair, wearing a colourful pink and purple spinal orthosis with black fastening straps. The slide includes the SMA Europe logo and symposium theme. Slide four: Green slide introducing the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation,” with the dates 4–5 March 2027 and location Prague, Czech Republic. Slide five: Green slide announcing the 2nd International Clinical Care Symposium on Spinal Muscular Atrophy, taking place on 4–5 March 2027 in Prague, Czech Republic. Slide six: Orange closing slide featuring the SMA Europe logo, , and [www.sma-europe.eu](http://www.sma-europe.eu).]

04/11/2026

📣 Our next SMAcademy webinar is coming up soon!

“Tracing patient experiences with SMA medicines, access, and treatment journeys in Europe: Open discussion on SMA Europe’s Pan-European Patient-Experience Survey”

🗓️ 17 November 2026
⏰ 14:00–15:30 CET

The SMA medicine and treatment landscape is changing rapidly. But how are people living with SMA navigating this increasingly complex environment?

To better understand these experiences, SMA Europe conducted the European Patient Experience Survey (EUPESMA), exploring access to SMA medicines and individual treatment journeys across Europe. The findings reveal that treatment journeys are not always straightforward. They can involve disruptions, delays and changes in direction, highlighting the importance of understanding individual experiences to improve care, support and advocacy.

💬 Join us for an interactive discussion!

We will share key findings from 826 people living with SMA and caregivers across more than 40 countries, while inviting patient advocates to reflect on the results and explore how we can turn these insights into meaningful action.

📌 Please note that the Q&A session will be open to patient advocates only.

🔗 You can register here: https://bit.ly/481o6D1

Together, 🌍



[Description of slides. Slide one: Blue slide announcing readers about the upcoming SMAcademy webinar, “Tracing patient experiences with SMA medicines, access, and treatment journeys in Europe: Open discussion on SMA Europe’s Pan-European Patient-Experience Survey,” taking place on 17 November 2026 from 14:30 to 16:00 CET. It notes that the SMAcademy Webinar Series is designed for patient advocates and that the Q&A session will be open to patient advocates only. Slide two: Blue closing slide with the SMA Europe logo, , and www.sma-europe.eu.]

04/11/2026

As SMA care evolves, rehabilitation approaches must respond to changing needs. 💜

Long-term follow-up and collaboration across medical specialities are important for addressing spinal and musculoskeletal complications.

At our 2nd Clinical and Care Symposium on SMA, specialists in orthopaedics, physiotherapy and rehabilitation, neurology, paediatrics, pulmonology and endocrinology will explore evolving challenges and approaches to care.

📢 Have research findings to share? Submit your abstract by 30 November 2026!

📅 4–5 March 2027
📍 Prague, Czechia
💻 Attend in person or online.

🔗 Learn more and register through the link: https://www.sma-europe.eu/clinical-care-symposium-prague-2027



[Description of images. Slide one: Portrait of Carole Vuillerot, Paediatric Physical Medicine and Rehabilitation Physician at Hospices Civils de Lyon. The slide features the SMA Europe logo and the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation.” Slide two: Green slide featuring a quote from Carole Vuillerot: “Our care must evolve as quickly as these patients do: we need to be as innovative in rehabilitation, orthopaedic and surgical management as the therapies themselves have been. This can only be achieved through a truly multidisciplinary approach bringing together therapists, orthopaedic surgeons, Physical and Rehabilitation Medicine physicians and neurologists around the same patient.” Slide three: Photograph of a young girl wearing an orange top and patterned leggings, practising walking with forearm crutches while a healthcare professional in blue scrubs and a face mask provides support in a rehabilitation room. The slide includes the SMA Europe logo and symposium theme. Slide four and five: Green slide introducing the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation,” with the dates 4–5 March 2027 and location Prague, Czech Republic. Slide six: Orange closing slide featuring the SMA Europe logo, , and [www.sma-europe.eu](http://www.sma-europe.eu).]

02/11/2026

How can better spine care support comfort, function and participation for people living with SMA? 💜

Early recognition and appropriate management of spinal deformities are important aspects of long-term care.

At our 2nd Clinical and Care Symposium on SMA, experts across orthopaedics, physiotherapy and rehabilitation, neurology, paediatrics, pulmonology and endocrinology will discuss spinal pathology, management and surgical approaches.

📅 4–5 March 2027
📍 Prague, Czechia
💻 Join us in person or online: https://www.sma-europe.eu/clinical-care-symposium-prague-2027

🔗 Learn more and register through the link: https://www.sma-europe.eu/clinical-care-symposium-prague-2027



[Description of images. Slide one: Portrait of Daniel Studer, Consultant Orthopaedic Surgeon at the University Children's Hospital Basel. The slide features the SMA Europe logo and the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation.” Slide two: Green slide featuring a quote from Daniel Studer: “With advances in SMA care transforming outcomes, attention to spinal health has never been more important. Early recognition and thoughtful management of spinal deformity can help preserve comfort, function, independence, and participation for patients and their families.” Slide three: Green and black medical illustration showing a close-up anatomical view of the spine, ribs, and spinal fixation rods and screws, alongside the SMA Europe logo and symposium theme. Slide four: Green slide introducing the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation,” with the dates 4–5 March 2027 and location Prague, Czech Republic. Slide five: Green slide announcing the 2nd International Clinical Care Symposium on Spinal Muscular Atrophy, taking place on 4–5 March 2027 in Prague, Czech Republic. Slide six: Orange closing slide featuring the SMA Europe logo, , , and [www.sma-europe.eu](http://www.sma-europe.eu).]

28/10/2026

How can hip complications in SMA be better prevented and managed?

Hip health remains an important consideration in SMA care, even as disease-modifying therapies continue to advance.

At our 2nd Clinical and Care Symposium on SMA, experts in orthopaedics, physiotherapy and rehabilitation, neurology, paediatrics, pulmonology and endocrinology will discuss hip pathology, management and surgical approaches.

📅 4–5 March 2027
📍 Prague, Czechia
💻 Participate in person or online: https://www.sma-europe.eu/clinical-care-symposium-prague-2027

🔗 Learn more and register through the link: https://www.sma-europe.eu/clinical-care-symposium-prague-2027


[Description of images. Slide one: Portrait of Giovanni Baranello, Consultant Paediatric Neurologist at Great Ormond Street Hospital for Children, smiling with short, curly dark-grey hair and wearing a navy blazer over a light blue shirt. The slide features the SMA Europe logo and the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation.” Slide two: Green slide featuring a quote from Giovanni Baranello: “Hip involvement in SMA has become an emerging hot topic for clinicians, patients, and caregivers. Despite the dramatic shift in long-term survival and motor function achieved through the approval of three disease-modifying therapies and the progressive worldwide rollout of newborn screening programmes, the vast majority of people living with SMA will experience hip complications at some point in their lives.” Slide three: Green and black medical illustration showing an anatomical view of the lower spine, pelvis and hip joints, alongside the SMA Europe logo and symposium theme. Slide four: Green slide introducing the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation,” with the dates 4–5 March 2027 and location Prague, Czech Republic. Slide five: Green slide announcing the 2nd International Clinical Care Symposium on Spinal Muscular Atrophy, taking place on 4–5 March 2027 in Prague, Czech Republic. Slide six: Orange closing slide featuring the SMA Europe logo, , and [www.sma-europe.eu](http://www.sma-europe.eu).]

26/10/2026

🔬 What's next for musculoskeletal care in SMA?

New scientific insights, unanswered questions and evolving clinical approaches are shaping the future of care.

Our 2nd Clinical and Care Symposium on SMA will bring together experts in orthopaedics, physiotherapy and rehabilitation, neurology, paediatrics, pulmonology and endocrinology to explore what comes next.

📅 4–5 March 2027
📍 Prague, Czechia
💻 Attend in person or online!

🔗 Learn more and register through the link: https://www.sma-europe.eu/clinical-care-symposium-prague-2027



[Description of images. Slide one: Portrait of Michail Kokkinakis, Consultant Orthopaedic Surgeon at Evelina London Children's Hospital, smiling with short dark-grey hair and wearing a light blue shirt. The slide features the SMA Europe logo and the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation.” Slide two: Green slide featuring a quote from Michail Kokkinakis: “Disease-Modifying Therapies (DMTs) significantly extended life expectancy and improved motor function in spinal muscular atrophy (SMA) but they also revealed uncertainties and unmasked challenges with regards to hip displacement, hip pain and muscle and joint contractures, previously considered insignificant and negligible. In this post-DMTs era, proactive orthopedic management has never been more vital.” Slide three: Photograph of a child wearing a blue T-shirt and red shorts, lying on a therapy mat with their legs raised and holding a large pink exercise ball, supported by a therapist. The slide includes the SMA Europe logo and symposium theme. Slide four: Green slide introducing the theme “Musculoskeletal Care in SMA: From Research to Rehabilitation,” with the dates 4–5 March 2027 and location Prague, Czech Republic. Slide five: Green slide announcing the 2nd International Clinical Care Symposium on Spinal Muscular Atrophy, taking place on 4–5 March 2027 in Prague, Czech Republic. Slide six: Orange closing slide featuring the SMA Europe logo, , and [www.sma-europe.eu](http://www.sma-europe.eu).]

Adresse

Im Moos 4
Freiburg Im Breisgau
79112

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn SMA Europe etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.

Kontaktieren Sie Die Organisation

Nachricht an SMA Europe senden:

Verknüpfungen

Teilen

Gemeinnützige Organisationen in der Nähe